MyCryptoMania

News

Brian Armstrong’s NewLimit Raises $435M for Human Trials

By

NewLimit raised $435M in Series C funding led by Founders Fund to advance its first age-reprogramming drug into human trials.

By

Related Post

News

Bitcoin price risks slide to $60K as Iran retaliates against U.S. strikes

News

What does the SEC’s new 2030 strategy mean for crypto regulation?

News

Microsoft Warns Crypto Wallets Face New npm Trojan Risk

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Interesting

The Hidden Number That Makes Global Payments Work

Interesting

El Salvador Buys the Dip as Bitcoin Slides Under $66,000, Reserve Nears 7,600 BTC

Discovery

The End Of An Era? Shiba Inu Burns Slow To A Crawl As Investors Lose Interest

Interesting

Mining as Metaphor: Turning Heat into Meaning